Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- 1 May 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 375 (9728), 1830-1843
- https://doi.org/10.1016/s0140-6736(10)60410-2
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Fluoroquinolone Resistance in Mycobacterium tuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosisScience, 2009
- Over the Counter Availability of Antituberculosis Drugs in Tbilisi, Georgia in the Setting of a High Prevalence of MDR-TBInterdisciplinary Perspectives on Infectious Diseases, 2009
- Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosisCurrent Opinion in Infectious Diseases, 2008
- Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testingProceedings of the National Academy of Sciences of the United States of America, 2008
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisThe New England Journal of Medicine, 2008
- Challenges in Estimating the Total Burden of Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Tuberculosis in London: the importance of homelessness, problem drug use and prisonThorax, 2007
- The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling ModelClinical Infectious Diseases, 2007